Pharmacogenomics applied to growth disorders: impact ofgenes on clinical and cellular responses to recombinant humangrowth hormone (r-hGH) and on Zebrafish growth

UoM administered thesis: Master of Philosophy

  • Authors:
  • Chiara De Leonibus

Abstract

There is significant inter-individual variation in growth response to recombinantgrowth hormone (r-hGH) in children with growth hormone deficiency (GHD).Clinical and biochemical factors influencing the r-hGH response have beenidentified, but current prediction models explain only 40 to 60% of its variability.Some of this unexplained variation may be attributable to genetic variants and theirpotential interactions with clinical and environmental factors.The aims of this thesis were: 1) to study the gene-environment interaction related tor-hGH response in children with GHD, and 2) to assess the functional activity of thegenetic variants in cell and animal models. For 1), phenotypic data were collected onpatients from the PREDICT Long Term Follow-Up Study (NCT00699855), whichhas identified predictive genetic markers related to r-hGH response. As latitudeaffects stature, a gene-environment interaction was assessed in relation tolatitude/summer daylight exposure (SDE) and carriage of seven SNPs previouslyassociated with high growth response. In addition, the relationship between basalgene expression (GE) in these children and the SDE/gene interaction was studied.For 2), the transcriptional activity of two genetic markers (GRB10 and SOS1) withthe greatest influence on response was tested. A morpholino oligonucleotidemediated knock-down of Grb10 in Zebrafish (ZF) was developed, as a preliminarystep to establish ZF as an animal model for testing genetic markers on growth.GHD patients from latitudes with higher SDE had a better 1st year height velocity(HV) compared to lower SDE (p=0.019), with HV over all groups correlating withSDE (r=0.256, p=0.006). There was a significant interaction between the SNP andSDE (p

Details

Original languageEnglish
Awarding Institution
Supervisors/Advisors
Award date1 Aug 2015